Metraipolis › archive › dc_6e6870eddff1
Retatrutide as a Unimolecular GIP/GLP-1/Glucagon Receptor Tri-Agonist: Molecular Design, Pharmaceutical Development and Critical Interpretation of Emerging… — Europe PMC PMID:42942810
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42942810
- DOI
- 10.3390/pharmaceutics18101277
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T05:35:40.430Z
- SHA-256 of the archived text
443d813973bc7d33c44e926443de2232dae0dba4f543715f3595e6026d1dbcfe- Stable URL of this page
https://metraipolis.com/documento/dc_6e6870eddff1
How to cite
Retatrutide as a Unimolecular GIP/GLP-1/Glucagon Receptor Tri-Agonist: Molecular Design, Pharmaceutical Development and Critical Interpretation of Emerging… — Europe PMC PMID:42942810 — Europe PMC (en), https://europepmc.org/article/MED/42942810 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6e6870eddff1 (Metraipolis archive dc_6e6870eddff1, sha256 443d813973bc7d33c44e926443de2232dae0dba4f543715f3595e6026d1dbcfe)
BibTeX
@misc{dc6e6870eddff1,
title = {Retatrutide as a Unimolecular GIP/GLP-1/Glucagon Receptor Tri-Agonist: Molecular Design, Pharmaceutical Development and Critical Interpretation of Emerging… — Europe PMC PMID:42942810},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42942810},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6e6870eddff1; sha256 443d813973bc7d33c44e926443de2232dae0dba4f543715f3595e6026d1dbcfe},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42942810. Agents can read the archived copy with the MCP tool read_document.